Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

AVITA Medical (RCEL) Interest Expenses (2018 - 2025)

AVITA Medical (RCEL) has disclosed Interest Expenses for 7 consecutive years, with $1.2 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Interest Expenses fell 3.7% year-over-year to $1.2 million, compared with a TTM value of $5.0 million through Dec 2025, down 6.66%, and an annual FY2025 reading of $5.0 million, down 6.66% over the prior year.
  • Interest Expenses was $1.2 million for Q4 2025 at AVITA Medical, down from $1.3 million in the prior quarter.
  • Across five years, Interest Expenses topped out at $1.4 million in Q3 2024 and bottomed at $4000.0 in Q1 2023.
  • Average Interest Expenses over 4 years is $822857.1, with a median of $1.2 million recorded in 2025.
  • The sharpest move saw Interest Expenses soared 33800.0% in 2024, then fell 9.07% in 2025.
  • Year by year, Interest Expenses stood at $6000.0 in 2022, then soared by 18600.0% to $1.1 million in 2023, then increased by 15.69% to $1.3 million in 2024, then dropped by 3.7% to $1.2 million in 2025.
  • Business Quant data shows Interest Expenses for RCEL at $1.2 million in Q4 2025, $1.3 million in Q3 2025, and $1.3 million in Q2 2025.